Project Grant R01AG100925
- The National Institute on Aging awarded a $539,635 Project Grant under the Aging Research program (CFDA 93.866) to The RAND Corporation to develop a family-based macro-simulation model examining the supply and demand of care for Alzheimer's disease and related dementias (ADRD). The project aims to simulate individual- and family-level economic and well-being outcomes based on the factors influencing ADRD caregiving, including care needs, caregiver availability, and the cost of formal care. The...
- The National Institute on Aging awarded The RAND Corporation $2.174 million on September 15, 2025, under the Aging Research program (CFDA 93.866) to assess medication access for opioid use disorder among Medicare beneficiaries. RAND will quantify and analyze beneficiary access to medications for opioid use disorder (MOUD)—methadone, buprenorphine, and naltrexone—and associated health outcomes for Medicare beneficiaries with opioid use disorder. The research will calculate reproducible...
- The National Institute on Aging awarded Emory University $535,656 for a project grant on September 1, 2026, under the Aging Research program (CFDA 93.866). The project, titled "Understand the Determinants and Quality Implications of Agency Staff Use in Nursing Homes: A Mixed Methods Study," examines how temporary staffing agencies impact resident outcomes and continuity of care across nursing homes. The study links payroll-based journal staffing data with national Medicare and resident...
- The Department of Health and Human Services National Institutes of Health Office of the Director awarded The Rand Corporation $569,003 on August 15, 2026, under the Aging Research program (CFDA 93.866) to conduct research on the effects of housing affordability and quality on chronic condition management and nursing home entry among low-income older adults. The award is structured as a Project Grant. The research investigates how variation in the Housing Choice Voucher program, the nation's...
- The National Institute on Aging awarded the University of California, Los Angeles $623,176 on September 1, 2026, under the Aging Research program (CFDA 93.866) to conduct research on modifiable risk factors for Alzheimer's disease and related dementias among individuals aged 90 and older. The research triangulates evidence across four data sources—the LifeAfter90 Study (1,397 participants, all aged 90), the 90+ Study (1,630 participants, all aged 90), the Health and Retirement Study (3,359...
- The National Institute on Aging awarded Education Development Center, Inc. $320,150 under the Aging Research program (CFDA 93.866) on September 1, 2026. The research project examines elder mistreatment and self-neglect among older adults with Alzheimer's disease and related dementias, leveraging the UCLA Alzheimer's and Dementia Care (ADC) Program's longitudinal dataset of structured data and clinical notes from dementia care specialists. The study expands the existing dataset to include three...
- The National Institute on Aging awarded The Rand Corporation $1.366 million on September 15, 2025, under the Aging Research program (CFDA 93.866) to conduct analyses of Medicare beneficiary access to medications for opioid use disorder and assess the impacts of state and federal policies on treatment disparities and health outcomes. The research examines barriers to access for the three FDA-approved medications to treat opioid use disorder: methadone, buprenorphine, and naltrexone. The study...
- The National Institute on Aging awarded the National Opinion Research Center $2.489 million on September 1, 2026, under the Aging Research program (CFDA 93.866) for a project grant (R01AG102939) titled "NSHAP Caregiver Study — Networks, Experiences, and Health Outcomes Across the Life Course." The recipient will conduct a comprehensive follow-up study of caregivers participating in Round 5 of the National Social Life, Health, and Aging Project. The project will collect original data...
- The National Institute on Aging awarded The University of Chicago $597,239 on September 1, 2026, under the Aging Research program (CFDA 93.866) to support investigation of inpatient rehabilitation facility (IRF) utilization and outcomes for older adult patients with and without Alzheimer's disease or other dementias (ADRD). The research examines comparative value and appropriateness of care delivery across post-acute care settings, specifically comparing higher-cost IRF care—which provides acute...
- The National Institute on Aging awarded $680,086 to The Regents of the University of California, San Francisco (UCSF) on April 1, 2026, under the Aging Research program (CFDA 93.866) to investigate how changes in primary care clinician work effort affect health outcomes for older adults. The research quantifies the number of Medicare patients affected by primary care clinician turnover and sustained reductions in billed clinical effort, identifies factors associated with these work effort...
The National Institute on Aging awarded The RAND Corporation $809,762 on September 1, 2026, under the Aging Research program (CFDA 93.866) to conduct a five-year study examining the relationship between workplace violence against health care workers in skilled nursing facilities and health outcomes for institutionalized residents with Alzheimer's disease and related dementias. RAND will link California state workers' compensation claims data—a previously unexamined source documenting incidents of health care worker violence—to patient-level Centers for Medicare and Medicaid Services administrative records spanning 2005–2024. The analysis will cover more than 1,000 California skilled nursing facilities and incorporate resident-level assessment data and high-frequency facility-level staffing data to identify risk factors for health care worker violence and measure its causal impacts on patient health. The study addresses a significant gap: while skilled nursing facilities have experienced a 30 percent rise in health care worker violence since 2011 and residents with Alzheimer's disease and related dementias comprise 58 percent of long-stay facility residents, systematic evidence linking staffing disruptions from violence incidents to patient outcomes has not been rigorously established. Place of performance is Santa Monica, California 90401. The period of performance runs from September 1, 2026, through May 31, 2031. The assistance type is a Project Grant.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $809.8k | 8/11/26 |